Bedel Financial Consulting, Inc. Edwards Lifesciences Corp Transaction History

Bedel Financial Consulting, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$86.5 - $128.27 $25,950 - $38,481	-300 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$83.84 - $104.76 $25,152 - $31,428	300 New	300 $31,000
Q2 2020 Jul 14, 2020	SELL	$57.54 - $76.95 $172 - $230	-3 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$52.41 - $81.0 $157 - $243	3 New	3 $1,000

1,378

454M

3.86M

3.32M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $56.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.